Chengdu, China

Xiaoqing Wang

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Chimagen Biosciences, Ltd.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaoqing Wang. Retrieved from https://idiyas.com/inventor/xiaoqing-wang-35sy7ygp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Xiaoqing Wang in Antibody Development

Introduction

Xiaoqing Wang is a prominent inventor based in Chengdu, China. She has made significant contributions to the field of biotechnology, particularly in the development of novel antibodies. Her work focuses on enhancing the stability and therapeutic applications of these antibodies.

Latest Patents

Xiaoqing Wang holds a patent for a covalent multi-specific antibody. This patent discloses novel bispecific and tri-specific antibodies that exhibit increased stability, which can be utilized for therapeutic purposes. This innovation represents a significant advancement in antibody technology.

Career Highlights

Xiaoqing Wang is currently employed at Chimagen Biosciences, Ltd. Her role at the company allows her to further her research and development efforts in the field of biopharmaceuticals. She has been instrumental in driving forward the company's innovative projects.

Collaborations

Xiaoqing collaborates with talented coworkers, including Zhenhao Zhou and Jie Zhang. These collaborations enhance the research environment and contribute to the success of their projects.

Conclusion

Xiaoqing Wang's contributions to the field of antibody development are noteworthy. Her innovative work in creating stable bispecific and tri-specific antibodies has the potential to impact therapeutic applications significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…